S Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research CDER Center for Biologics Evaluation and Research CBER October 2000 User Fees Revision 1 Guidance for Industry Submitting and Reviewing Com ID: 4232
DownloadNote - The PPT/PDF document "Guidance for Industry Submitting and Rev..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Next Slides
Guidance for industry considerations for the design of early
Guidance on reviewing and reporting unanticipated problems i
Guidance for industry e14 clinical evaluation of qt/qtc in
Guidance for industry
Guidance for industry computerized systems used in clinical
Guidance on legislation clinical investigations of medical d
Guidance for industry oversight of clinical investigations a
Guidance for industry clinical data needed to support the li
Guidance for industry oversight of clinical investigations